4//SEC Filing
CLEVELAND BIOLABS INC 4
Accession 0001209191-15-036226
CIK 0001318641operating
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 7:12 PM ET
Size
5.5 KB
Accession
0001209191-15-036226
Insider Transaction Report
Form 4
SALUCK RANDY S.
Director
Transactions
- Award
Stock Option (right to buy)
2015-04-22+16,000→ 16,000 totalExercise: $3.20From: 2015-07-14Exp: 2025-04-22→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option will become exercisable with respect to 25% of the total shares on July 14, 2015, for 50% of the total shares on October 14, 2015, for 75% of the total shares on January 14, 2016, and 100% of the total shares on April 14, 2016.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001318641
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 7:12 PM ET
- Size
- 5.5 KB